Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms.
Shin-Yi Lin, Yu-Kai Chen, Hui-Tzu Yu, Gayane S Barseghyan, Mikheil D Asatiani, Solomon P Wasser, Jeng-Leun Mau
Index: Int. J. Med. Mushrooms 15(3) , 315-23, (2013)
Full Text: HTML
Abstract
Mushrooms (including fruiting bodies and mycelia) contain several bioactive components such as lovastatin, γ-aminobutyric acid (GABA), and ergothioneine. This article reports the results of 49 samples, including 9 fruiting bodies, 39 mycelia, and 1 vegetative cell, of 35 species of culinary-medicinal mushrooms from 18 genera: Agaricus, Agrocybe, Coprinus, Cordyceps, Cyathus, Daedalia, Flammulina, Fomes, Ganoderma, Grifola, Laetiporus, Lentinus, Morchella, Ophiocordyceps, Pleurotus, Trametes, Tremella, and Verpa. The results show that Cyathus striatus strain 978 contained the highest amount of lovastatin (995.66 mg/kg) in mycelia. Among fruiting bodies, 6 samples contained a high amount of GABA (274.86-822.45 mg/kg), whereas among mycelia, contents of GABA in 27 samples ranged from 215.36 to 2811.85 mg/kg. Among mycelia, Pleurotus cornucopiae strain 1101 contained the highest amount of ergothioneine (3482.09 mg/kg). Overall, these 3 bioactive components were commonly found in most mushrooms, and the results obtained might be related to their beneficial effects.
Related Compounds
Related Articles:
Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells.
2014-11-01
[Gynecol. Oncol. 135(2) , 333-41, (2014)]
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2011-12-01
[J. Sci. Ind. Res. 65(10) , 808, (2006)]
A predictive ligand-based Bayesian model for human drug-induced liver injury.
2010-12-01
[Drug Metab. Dispos. 38 , 2302-8, (2010)]
2015-01-01
[Pharmacol. Res. 91 , 69-77, (2015)]